Why is Jagsonpal Pharma falling/rising?

As of 26-Sep, Jagsonpal Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 214.45, which reflects a decrease of Rs 20.5 or 8.73%. The stock has underperformed its sector by 6.39% today and has been on a downward trend for the past three days, accumulating a total loss of 11.33%. It opened with a loss of 2.53% and reached an intraday low of Rs 211.7, indicating significant volatility with an intraday fluctuation of 5.15%. Additionally, the stock is trading below its moving averages across various time frames, and there has been a notable drop in investor participation, with delivery volume falling by 63.33% compared to the five-day average. Despite a strong long-term performance, with a 29.94% return over the past year, the recent short-term declines are overshadowing these gains.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as it has declined by 11.66% over the past week while the Sensex has only fallen by 2.66%. This underperformance highlights the stock's current struggles amidst a generally weak sentiment in the pharmaceuticals and drugs sector, which has also seen a decline of 2.34%. Although Jagsonpal Pharmaceuticals has demonstrated healthy long-term growth, with significant increases in operating profit and net sales, the recent price movements suggest that short-term pressures and declining investor interest are impacting its stock negatively.